2016 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

News

 

FDA Clears Medtronic’s TrailBlazer Angled Peripheral Support Catheter

September 28, 2016 -- Medtronic plc announced that the US Food and Drug Administration (FDA) has cleared the TrailBlazer angled support catheter for use in the peripheral vasc…

ARTESp Study Demonstrates Safety and Efficacy of Phenox Preset Thrombectomy Device

September 28, 2016 -- Phenox GmbH announced that results of the ARTESp study were recently published online ahead of print by Sascha Prothmann, MD, et al in the Journal o…

SVS Announces New PAD Reporting Standards

September 28, 2016 -- The Society for Vascular Surgery (SVS) announced the release of new reporting standards focused on endovascular treatment of chronic lower extremity peri…

CMS Approves New Technology Add-On Payment for Gore’s Excluder Iliac Branch Endoprosthesis

September 27, 2016 -- Gore & Associates announced that the Centers for Medicare & Medicaid Services (CMS) has granted the company’s Excluder iliac branch en…

HERMES Meta-Analysis Evaluates Time to Treatment of Endovascular Thrombectomy for Stroke

September 27, 2016 -- Jeffrey L. Saver, MD, et al published findings from the HERMES trial in the Journal of American Medical Association (JAMA; 2016;316:1279 -…

One-Year Results Presented From the Gore Viabahn Japan IDE Clinical Study

September 21, 2016 -- Gore & Associates, Inc. announced positive results from the prospective multicenter investigational device exemption (IDE) clinical study, which occu…

Click here for more News coverage

Current Supplements

Sponsored by BOSTON SCIENTIFIC CORPORATION

What Is the Future of Interventional Oncology?

Interventional radiologists discuss current and future needs to make IR the next pillar in cancer treatment.

Current European Supplement

Sponsored by Spectranetics

Evidence From the Next-Generation DCB

More With Less

Featured Center

 

Embolization

advertisement

 
Vascular Market Price  Change
Abbott Laboratories $42.29  2.05%
AstraZeneca PLC $32.86  -0.57%
Avinger $4.77  6.24%
Boston Scientific Corporation $23.80  2.15%
Cardinal Health $77.70  1.04%
Cardiovascular Systems Inc. $23.74  3.89%
CR Bard Inc. $224.28  0.24%
Edwards Lifesciences Corp. $120.56  1.09%
Endologix Inc. $12.80  3.31%
Johnson and Johnson $118.13  0.73%
Vascular Market Price  Change
Lombard Medical, Inc. $0.95  3.25%
Medtronic, Inc. $86.40  1.17%
Merit Medical Systems, Inc. $24.29  2.23%
Penumbra, Inc. $75.99  1.36%
St. Jude Medical Inc. $79.76  1.01%
Stryker $116.41  0.61%
The Medicines Company $37.74  -0.97%
The Spectranetics Corporation $25.09  3.81%
Vascular Solutions Inc. $48.23  1.64%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.